Turnstone Biologics Corp
TSBX
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.21M
Close$
$-0.24
167.9% downside
Current Fair Value
167.9% downsideOvervalued by 167.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.21 Million |
|---|---|
| Enterprise Value | $-8,062,051.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.07 |
| Beta | 1.37 |
| Outstanding Shares | 23,140,510 |
Return
| Return on Equity | -319.70% |
|---|---|
| Return on Assets | -223.60% |
| Return on Invested Capital | -301.20% |
Valuation & Multiples
| P/E Ratio | -0.27 |
|---|---|
| PEG | 0.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.18 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.05 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 36.45%▼ 8.47% |
|---|---|
| Total Invested | $3.03M▼ 28.95% |
| Investors Holding | 230% |
ESG Score
No data